n-(3,4,5-trichlorophenyl)succinimide has been researched along with diclofenac in 1 studies
Studies (n-(3,4,5-trichlorophenyl)succinimide) | Trials (n-(3,4,5-trichlorophenyl)succinimide) | Recent Studies (post-2010) (n-(3,4,5-trichlorophenyl)succinimide) | Studies (diclofenac) | Trials (diclofenac) | Recent Studies (post-2010) (diclofenac) |
---|---|---|---|---|---|
7 | 0 | 2 | 8,874 | 1,874 | 3,616 |
Protein | Taxonomy | n-(3,4,5-trichlorophenyl)succinimide (IC50) | diclofenac (IC50) |
---|---|---|---|
Aldo-keto reductase family 1 member B10 | Homo sapiens (human) | 1.9 | |
Prostaglandin G/H synthase 1 | Bos taurus (cattle) | 0.003 | |
Prostaglandin G/H synthase 1 | Ovis aries (sheep) | 1.3376 | |
Interleukin-8 | Homo sapiens (human) | 0.008 | |
Prostaglandin G/H synthase 1 | Homo sapiens (human) | 0.0415 | |
Sodium- and chloride-dependent GABA transporter 1 | Rattus norvegicus (Norway rat) | 0.5 | |
C-X-C chemokine receptor type 1 | Homo sapiens (human) | 0.012 | |
Sodium- and chloride-dependent GABA transporter 2 | Rattus norvegicus (Norway rat) | 0.5 | |
Sodium- and chloride-dependent GABA transporter 3 | Rattus norvegicus (Norway rat) | 0.5 | |
Prostaglandin G/H synthase 2 | Homo sapiens (human) | 0.4165 | |
Prostaglandin G/H synthase 2 | Rattus norvegicus (Norway rat) | 0.5 | |
Sodium- and chloride-dependent betaine transporter | Rattus norvegicus (Norway rat) | 0.5 | |
Prostaglandin G/H synthase 2 | Ovis aries (sheep) | 1.6867 | |
Prostaglandin G/H synthase 2 | Mus musculus (house mouse) | 0.0502 | |
Solute carrier family 22 member 6 | Homo sapiens (human) | 4 | |
Prostaglandin G/H synthase 1 | Rattus norvegicus (Norway rat) | 0.5 | |
P2Y purinoceptor 12 | Rattus norvegicus (Norway rat) | 0.02 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abdel-Aziz, AA; Asiri, YA; ElTahir, KE | 1 |
1 other study(ies) available for n-(3,4,5-trichlorophenyl)succinimide and diclofenac
Article | Year |
---|---|
Synthesis, anti-inflammatory activity and COX-1/COX-2 inhibition of novel substituted cyclic imides. Part 1: Molecular docking study.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Crystallography, X-Ray; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Disease Models, Animal; Edema; Hydrogen Bonding; Imides; Male; Models, Molecular; Molecular Structure; Rats; Rats, Sprague-Dawley; Sheep; Stereoisomerism; Structure-Activity Relationship | 2011 |